Learn More
Medchemexpress LLC Tigecycline | 220620-09-7 | 99.9% | 500 MG

Supplier: Medchemexpress LLC HYB0117500MG
Tigecycline (GAR-936) is a broad-spectrum glycylcycline antibiotic. It demonstrates activity against various bacteria, including E. coli with a mean inhibitory concentration (MIC) of approximately 125 ng/mL, and Acinetobacter baumannii with MIC50 and MIC90 values of 1 and 2 mg/L, respectively. In vitro studies show Tigecycline inhibits AML2 and HL-60 human leukemia cells. In vivo, it has been shown to reduce tumor volume and weight in NOD/SCID mice models of acute myeloid leukemia. Pharmacokinetic studies in mice indicate a Cmax of 22.8 μg/mL and a terminal half-life of 108.9 min in saline.
- Broad-spectrum glycylcycline antibiotic
- Inhibits AML2 and HL-60 human leukemia cells in vitro
- Reduces tumor volume and weight in NOD/SCID mice xenograft models
- Well-characterized pharmacokinetic profile in animal models
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.